BG Medicine to Present at ISRTP Workshop: Progress and Barriers to Incorporating Alternative Toxicological Methods in the U.S.WALTHAM, Mass. -- BG Medicine today announced that it is scheduled to give a presentation at the International Society of Regulatory Toxicology toxicology, study of poisons, or toxins, from the standpoint of detection, isolation, identification, and determination of their effects on the human body. Toxicology may be considered the branch of pharmacology devoted to the study of the poisonous effects of drugs. and Pharmacology pharmacology, study of the changes produced in living animals by chemical substances, especially the actions of drugs, substances used to treat disease. Systematic investigation of the effects of drugs based on animal experimentation and the use of isolated and Workshop: Progress and Barriers to Incorporating Alternative Toxicological Methods in the U.S. on November 17, 2005 at 1:30pm (ET) at the Marriott Waterfront Hotel in Baltimore, MD. Pieter Muntendam MD, President of BG Medicine, will present under the title "Computational Approach to Systems Toxicology - a Common Path to Mechanism and Biomarkers". Dr. Muntendam will use the recently announced FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. Critical Path collaboration between BG Medicine and the FDA regarding liver toxicity of drugs to illustrate observations and views regarding barriers to innovating toxicity testing. The objective of the Workshop is to explore progress to date in implementing new, revised and alternative toxicological test methods across regulatory evaluation frameworks and decision-making programs in the U.S., identify barriers to progress and explore potential bridges to facilitate overcoming such barriers. These barriers may be technical, regulatory, economic or societal. About BG Medicine BG Medicine is pioneering the commercial application of Systems Pharmacology, which is based on scientific advances in the Systems Biology Systems biology, a field of study in the biosciences, focuses on the systematic study of complex interactions in biological systems. Particularly from 2000 onwards, the term is used widely in the biosciences, and in a variety of contexts. field. Its advanced proprietary platform enables novel paths to new medicines through molecular fingerprinting fingerprinting Act of taking an impression of a person's fingerprint. Because each person's fingerprints are unique, fingerprinting is used as a method of identification, especially in police investigations. of genes, proteins, and metabolites Metabolites Substances produced by metabolism or by a metabolic process. Mentioned in: Interactions combined with powerful bioinformatics integration. For more information about BG Medicine please visit www.bg-medicine.com or contact Scott A. Wallace, Vice President, Business Development at 781-434-0230. NOTE TO EDITORS: See also "FDA and Industry to Collaborate on Better Ways to Predict Liver Toxicity in Human Drug Trials - Part of FDA's Critical Path Initiative to Modernizing Drug Development" released November 2, 2005 by the FDA. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion